The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury
Abstract
BACKGROUND: This study aimed to investigate the effects of methylphenidate and sertraline compared with placebo on various neuropsychiatric sequelae associated with traumatic brain injury (TBI). METHODS: This was a 4 week, double-blind, parallel-group trial. Thirty patients with mild to moderate degrees of TBI were randomly allocated to one of three treatment groups (n = 10 in each group) with matching age, gender and education, i.e. methylphenidate (starting at 5 mg/day and increasing to 20 mg/day in a week), sertraline (starting at 25 mg/day and increasing to 100 mg/day in a week) or placebo. At the baseline and at the 4 week endpoint, the following assessments were administered: subjective (Beck Depression Inventory) and objective (Hamilton Depression Rating Scale) measures of depression; Rivermead Postconcussion Symptoms Questionnaire for postconcussional symptoms; SmithKline Beecham Quality of Life Scale for quality of life; seven performance tests (Critical Flicker Fusion, Choice Reaction Time, Continuous Tracking, Mental Arithmetic, Short-Term memory, Digit Symbol Substitution and Mini-Mental State Examination); subjective measures of sleep (Leeds Sleep Evaluation Questionnaire) and daytime sleepiness (Epworth Sleepiness Scale). All adverse events during the study period were recorded and their relationships to the drugs were assessed. RESULTS: Neuropsychiatric sequelae seemed to take a natural recovery course in patients with traumatic brain injury. Methylphenidate had significant effects on depressive symptoms compared with the placebo, without hindering the natural recovery process of cognitive function. Although sertraline also had significant effects on depressive symptoms compared with the placebo, it did not improve many tests on cognitive performances. Daytime sleepiness was reduced by methylphenidate, while it was not by sertraline. CONCLUSIONS: Methylphenidate and sertraline had similar effects on depressive symptoms. However, methylphenidate seemed to be more beneficial in improving cognitive function and maintaining daytime alertness. Methylphenidate also offered a better tolerability than sertraline.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale
Johns, M. W. (1991) · Sleep · doi:10.1093/sleep/14.6.540 · Cited by 17,364
King, N. S., Crawford, S., Wenden, F. J., Moss, N. E. G., & Wade, D. T. (1995) · Journal of Neurology · doi:10.1007/bf00868811 · Cited by 1,460
The epidemiology of traumatic brain injury: a review
Bruns, J., & Hauser, W. A. (2003) · Epilepsia · doi:10.1046/j.1528-1157.44.s10.3.x · Cited by 1,271
Major Depression Following Traumatic Brain Injury
Jorge, R. E., Robinson, R. G., Moser, D., Tateno, A., Crespo-Facorro, B., & Arndt, S. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.42 · Cited by 737
Cited by
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
Treatment for Depression after Traumatic Brain Injury: A Systematic Review
Fann, J. R., Hart, T., & Schomer, K. G. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2009.1091 · Cited by 329
Depression and cognitive complaints following mild traumatic brain injury
Silver, J. M., McAllister, T. W., & Arciniegas, D. B. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.08111676 · Cited by 315
“(54), comparing the effects of sertraline and methylphenidate on depression after mild to moderate TBI, reported reductions of depressive symptoms with both agents, but more substantial improvements in cognition and daytime fatigue with methylphenidate.”
BackgroundPersistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis
Bales, J. W., Wagner, A. K., Kline, A. E., & Dixon, C. E. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.03.011 · Cited by 264
Diaz-Arrastia, R., Kochanek, P. M., Bergold, P., Kenney, K., Marx, C. E., Grimes, C. J. B., Loh, L. Y., Adam, L. G. E., Oskvig, D., Curley, K. C., et al. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2013.3019 · Cited by 262
Sleep-wake disturbances after traumatic brain injury
Ouellet, M.-C., Beaulieu-Bonneau, S., & Morin, C. M. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00068-x · Cited by 231
Prado, C. E., Watt, S., & Crowe, S. F. (2018) · Neuropsychology Review · doi:10.1007/s11065-018-9369-5 · Cited by 188
Psychostimulants for depression
Candy, B., Jones, L., Williams, R., Tookman, A., & King, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006722.pub2 · Cited by 156
Depression Following Traumatic Brain Injury: Epidemiology, Risk Factors and Management
Rapoport, M. J. (2012) · CNS Drugs · doi:10.2165/11599560-000000000-00000 · Cited by 125
Juengst, S. B., Kumar, R. G., & Wagner, A. K. (2017) · Psychology Research and Behavior Management · doi:10.2147/prbm.s113264 · Cited by 102
“Other potential avenues for research that may reveal effective treatments for PTD include methylphenidate 118,151 and mindfulness-based interventions.”
Fann, J. R., Bombardier, C. H., Temkin, N., Esselman, P., Warms, C., Barber, J., & Dikmen, S. (2017) · Journal of Head Trauma Rehabilitation · doi:10.1097/htr.0000000000000322 · Cited by 82
“88 30-44 15 (48) 13 (42) 45-59 6 (19) 7 (23) ≥60 2 (6) 1 (3) Sex Female 8 (26) 7 (23) 1.”
The Efficacy of Psychostimulants in Major Depressive Episodes: A Systematic Review and Meta-Analysis
McIntyre, R. S., Lee, Y., Zhou, A. J., Rosenblat, J. D., Peters, E. M., Lam, R. W., Kennedy, S. H., Rong, C., & Jerrell, J. M. (2017) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000723 · Cited by 75
Iglewicz, A., Morrison, K., Nelesen, R. A., Zhan, T., Iglewicz, B., Fairman, N., Hirst, J. M., & Irwin, S. A. (2015) · Psychosomatics · doi:10.1016/j.psym.2014.05.005 · Cited by 60
Rao, V., Bechtold, K., McCann, U., Roy, D., Peters, M., Vaishnavi, S., Yousem, D., Mori, S., Yan, H., Leoutsakos, J., et al. (2019) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.17110338 · Cited by 60
The Effect of Antidepressants on Depression After Traumatic Brain Injury: A Meta-analysis
Kreitzer, N., Ancona, R., McCullumsmith, C., Kurowski, B. G., Foreman, B., Ngwenya, L. B., & Adeoye, O. (2019) · Journal of Head Trauma Rehabilitation · doi:10.1097/htr.0000000000000439 · Cited by 56
Beedham, W., Belli, A., Ingaralingam, S., Haque, S., & Upthegrove, R. (2020) · Brain Injury · doi:10.1080/02699052.2020.1797169 · Cited by 41
Psychiatric phenotypes in chronic traumatic encephalopathy
Mahar, I., Alosco, M. L., & McKee, A. C. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.08.023 · Cited by 36
“…inhibitors (SSRIs) may be effective in treating post-TBI depression, particularly for citalopram and sertraline, although the latter may not be advisable due to adverse treatment effects potentially related to post-injury symptoms (Fann et al., 2009; Lee et al., 2005; Wheaton et al., 2011).”
Hypocretin Mediates Sleep and Wake Disturbances in a Mouse Model of Traumatic Brain Injury
Thomasy, H. E., & Opp, M. R. (2019) · Journal of Neurotrauma · doi:10.1089/neu.2018.5810 · Cited by 35
Narapareddy, B. R., Narapareddy, L., Lin, A., Wigh, S., Nanavati, J., Dougherty, J., Nowrangi, M., & Roy, D. (2020) · Psychosomatics · doi:10.1016/j.psym.2020.04.012 · Cited by 23
Cheng, Y.-S., Tseng, P.-T., Wu, Y.-C., Tu, Y.-K., Wu, C.-K., Hsu, C.-W., Lei, W.-T., Li, D.-J., Chen, T.-Y., Stubbs, B., et al. (2021) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.190122 · Cited by 16
“28 Because executive dysfunction is a frequent comorbidity of TBI-related depression, 4 methylphenidate may further improve depressive symptoms by enhancing cognitive function.”
BackgroundGao, C., Fu, Q., Chen, P., Liu, Z., & Zhou, Q. (2019) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2019.06.050 · Cited by 9
Metadata
- Authors
- Lee, H., Kim, S.-W., Kim, J.-M., Shin, I.-S., Yang, S.-J., & Yoon, J.-S.
- Venue
- Human Psychopharmacology: Clinical and Experimental
- Publisher
- Wiley
- Published
- 2005
- Volume
- 20
- Issue
- 2
- Pages
- 97-104
- ISSN
- 0885-6222 (ISSN-L)
- 1099-1077
- OpenAlex
- W1970159591
- Cited by
- 206
- References
- 4
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.